Biofunctionalized nanomaterials for Parkinson's disease theranostics: potential for efficient PD biomarker detection and effective therapy
Publication type: Journal Article
Publication date: 2025-02-19
scimago Q1
wos Q2
SJR: 1.215
CiteScore: 11.4
Impact factor: 5.7
ISSN: 20474830, 20474849
Abstract
α-Synuclein (α-Syn) is a primary pathological indicator for Parkinson's disease (PD). The α-Syn oligomer is even more toxic and is responsible for PD. Hence, identifying α-Syn and its oligomers is an interesting approach to diagnosing PD. The prevention strategies for oligomer formation could be therapeutic in treating PD. Various conventional strategies have been developed for the management of PD. However, their clinical applications are limited due to toxicity, off-targeting, side effects, and poor bioavailability. Recently, nanomaterials have gained significant attention due to unique physicochemical characteristics such as nanoscale size, large surface area, flexibility of functionalization, and ability to protect and control a loaded payload. Functionalizing the surface of nanoparticles with a desired targeting agent could offer targeted delivery of the payload at the site of action due to specificity and selectivity against complementary molecules. Among various functionalization approaches, biomolecule-functionalized nanomaterials offer benefits such as enhanced bioavailability, improved internalization into target cells through receptor-mediated endocytosis, and delivery of therapeutics across the BBB (blood–brain barrier). In this review, we initially discussed the major milestones related to PD and highlighted the therapeutic strategies focused on clinical trials. The strategies of biomolecule functionalization of nanomaterials and their application in detecting and preventing α-Syn oligomer for the diagnosis and therapy of PD, respectively, have been reviewed comprehensively. Ultimately, we have outlined the conclusions, highlighted the limitations and challenges, and provided insight into future perspectives and alternative approaches that must be investigated.
Found
Nothing found, try to update filter.
Found
Nothing found, try to update filter.
Are you a researcher?
Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
8
Total citations:
8
Citations from 0:
0
Cite this
GOST |
RIS |
BibTex |
MLA
Cite this
GOST
Copy
Sabnam S., Kumar R., Pranav Biofunctionalized nanomaterials for Parkinson's disease theranostics: potential for efficient PD biomarker detection and effective therapy // Biomaterials Science. 2025. Vol. 13. No. 9. pp. 2201-2234.
GOST all authors (up to 50)
Copy
Sabnam S., Kumar R., Pranav Biofunctionalized nanomaterials for Parkinson's disease theranostics: potential for efficient PD biomarker detection and effective therapy // Biomaterials Science. 2025. Vol. 13. No. 9. pp. 2201-2234.
Cite this
RIS
Copy
TY - JOUR
DO - 10.1039/d5bm00179j
UR - https://xlink.rsc.org/?DOI=D5BM00179J
TI - Biofunctionalized nanomaterials for Parkinson's disease theranostics: potential for efficient PD biomarker detection and effective therapy
T2 - Biomaterials Science
AU - Sabnam, Saheli
AU - Kumar, Raj
AU - Pranav
PY - 2025
DA - 2025/02/19
PB - Royal Society of Chemistry (RSC)
SP - 2201-2234
IS - 9
VL - 13
SN - 2047-4830
SN - 2047-4849
ER -
Cite this
BibTex (up to 50 authors)
Copy
@article{2025_Sabnam,
author = {Saheli Sabnam and Raj Kumar and Pranav},
title = {Biofunctionalized nanomaterials for Parkinson's disease theranostics: potential for efficient PD biomarker detection and effective therapy},
journal = {Biomaterials Science},
year = {2025},
volume = {13},
publisher = {Royal Society of Chemistry (RSC)},
month = {feb},
url = {https://xlink.rsc.org/?DOI=D5BM00179J},
number = {9},
pages = {2201--2234},
doi = {10.1039/d5bm00179j}
}
Cite this
MLA
Copy
Sabnam, Saheli, et al. “Biofunctionalized nanomaterials for Parkinson's disease theranostics: potential for efficient PD biomarker detection and effective therapy.” Biomaterials Science, vol. 13, no. 9, Feb. 2025, pp. 2201-2234. https://xlink.rsc.org/?DOI=D5BM00179J.
Profiles